Duke-NUS team reveals unknown mechanisms of zika infection

Biologics |  News | 0 Comment | 05 Mar, 2019

Researchers at Duke-NUS Medical School and their colleagues have identified a surprising interaction between dengue and ...Read more

Data sharing uncovers five new risk genes for Alzheimer’s disease

Biologics |  News | 0 Comment | 04 Mar, 2019

Analysis of genetic data from more than 94,000 individuals has revealed five new risk genes for Alzheimer’s diseas...Read more

Adagene to evaluate dynamic precision library platform with Celgene

Biologics |  Regulatory | 4 Comment | 04 Mar, 2019

China based Adagene, Inc., an innovative antibody discovery and engineering company, has announced a multi-target platfo...Read more

Link between GSL antigens and tumor survival in breast cancer found in a new research

Biologics |  News | 0 Comment | 19 Feb, 2019

A team led by Dr. Chi-Huey Wong, Distinguished Research Fellow, Academia Sinica in Taiwan, in collaboration with OBI sci...Read more

Chipscreen Biosciences unites with Innovent for colorectal cancer therapy

Biologics |  News | 0 Comment | 18 Feb, 2019

Chipscreen Biosciences, a leading integrated Chinese biotech company specialized in discovery and development of novel s...Read more

Singapore researchers reveal role of anti-parasitic drug in treating cancer

Biologics |  News | 0 Comment | 15 Feb, 2019

Scientists from A*STAR’s Institute of Molecular and Cell Biology (IMCB) have discovered that niclosamide, an FDA-a...Read more

Researchers develop potential therapeutic model for Parkinson’s disease

Biologics |  News | 1 Comment | 12 Feb, 2019

Parkinson's disease (PD) is the second most common neurodegenerative disorder, implicating 10 million people worldwide b...Read more

Duke-NUS researchers reveal novel immune study on dengue

Biologics |  News | 0 Comment | 08 Feb, 2019

Researchers at Duke-NUS Medical School have demonstrated for the first time a physical interaction between two types of ...Read more

NUS researchers study nanoparticles’ role in cancer metastasis

Biologics |  News | 0 Comment | 04 Feb, 2019

Nanoparticles can be found in processed food (e.g. food additives), consumer products (e.g. sunscreen) and even in medic...Read more

Researchers in Japan develop strategy to strengthen skeletal muscles

Biologics |  News | 1 Comment | 01 Feb, 2019

Hokkaido University researchers have developed a strategy to fabricate materials that become stronger in response to mec...Read more

Alvotech raises $300mn to further biosimilar development

Biologics |  News | 0 Comment | 24 Jan, 2019

Alvotech has successfully raised US$300 million through a private bond offering. Net proceeds from the capital raised ...Read more

Novel device by NUS aids in muscle recovery

Biologics |  News | 2 Comment | 24 Jan, 2019

A team of NUS researchers has developed a novel medical device capable of harnessing a magnetic field to make muscle reh...Read more

I-Mab Biopharma gets USFDA IND nod for antibody TJD5

Biologics |  News | 0 Comment | 23 Jan, 2019

China-based clinical stage biopharmaceutical company, I-Mab Biopharma, exclusively focused on the development of innovat...Read more

Mechanical stress may affect normal bone development

Biologics |  News | 0 Comment | 21 Jan, 2019

The bone matrix contains various proteins, namely, collagen and other non-collagenous proteins. Osteoblasts are responsi...Read more

Branched-Chain amino acids can regulate progression of Cancer: Research

Biologics |  News | 0 Comment | 21 Jan, 2019

Researchers at A*STAR's Singapore Bioimaging Consortium (SBIC) have discovered that branched-chain amino acids (BCAAs) i...Read more

Ribon Therapeutics raises $65M

Biologics |  News | 0 Comment | 07 Jan, 2019

Ribon Therapeutics, a biotechnology company developing first-in-class therapeutics targeting novel enzyme families activ...Read more

Tizona Therapeutics appoints Scott Clarke as CEO

Biologics |  News | 0 Comment | 05 Jan, 2019

US based biotech company, Tizona Therapeutics has announced that Scott Clarke has joined the company as its chief execut...Read more

Betta Pharma uses ProBioGen's technology for cancer treatment

Biologics |  News | 0 Comment | 03 Jan, 2019

ProBioGen AG, a premier service & technology provider for complex therapeutic antibodies and glycoproteins, announce...Read more